While GLP-1 receptor agonists have been extensively studied for blood sugar and weight control, new research highlights their broader effectsespecially at lower doses: Cognitive Function & Brain Health A 2021 study published in Life Sciences found that GLP-1 medication reduced both systemic and central nervous system inflammation in a rodent model
Its essential to consult with your healthcare provider before stopping the medication
Zhou Y, Suo W, Zhang X, Liang J, Zhao W, Wang Y, Li H, Ni Q
I would recommend not spending any money on these because I dont think theyre going to do anything meaningful, she says
Most headaches occur during initial weeks or following dose increases and typically diminish as your body adapts
Related Reading Semaglutide vs Tirzepatide: Which GLP-1 Is Right for You